ICON Public Limited Company(ICLR)Earnings, Financials & Key Ratios
ICLR•NASDAQ
50.3× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryContract Research and Preclinical Services
AboutICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.Show more
- Revenue$8.25B-0.4%
- EBITDA$1.4B-12.0%
- Net Income$229M-71.0%
- EPS (Diluted)2.90-69.6%
- Gross Margin26.37%-10.4%
- EBITDA Margin16.91%-11.7%
- Operating Margin12.27%-7.4%
- Net Margin2.78%-70.9%
- ROE2.45%-71.0%
ICLR Key Insights
ICON Public Limited Company (ICLR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 24.2%
- ✓Share count reduced 4.9% through buybacks
- ✓Trading at only 1.3x book value
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ICLR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ICLR Price & Volume
ICON Public Limited Company (ICLR) stock price & volume — 10-year historical chart
Loading chart...
ICLR Growth Metrics
ICON Public Limited Company (ICLR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years18.01%
5 Years24.15%
3 Years2.15%
TTM-1.3%
Profit CAGR
10 Years-0.43%
5 Years-6.9%
3 Years-23.15%
TTM-38.26%
EPS CAGR
10 Years-3.09%
5 Years-14.21%
3 Years-22.08%
TTM-35.36%
Return on Capital
10 Years14.58%
5 Years6.34%
3 Years7.3%
Last Year7.46%
ICLR Recent Earnings
ICON Public Limited Company (ICLR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 28, 2026Metric
Actual
Est
EPS
$2.52-14.6%
$2.95
Rev
$2.1B+6.6%
$2.0B
Q2 2026
May 27, 2026Metric
Actual
Est
EPS
$2.52-19.5%
$3.13
Rev
$2.1B+6.6%
$2.0B
Q2 2026
Apr 29, 2026Metric
Actual
Est
EPS
$3.28+2.8%
$3.19
Rev
$2.0B+0.5%
$2.0B
Q4 2025
Oct 22, 2025Metric
Actual
Est
EPS
$3.31+0.9%
$3.28
Rev
$2.0B+3.0%
$2.0B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 28, 2026 | $2.52vs $2.95-14.6% | $2.1Bvs $2.0B+6.6% |
| Q2 2026 | May 27, 2026 | $2.52vs $3.13-19.5% | $2.1Bvs $2.0B+6.6% |
| Q2 2026 | Apr 29, 2026 | $3.28vs $3.19+2.8% | $2.0Bvs $2.0B+0.5% |
| Q4 2025 | Oct 22, 2025 | $3.31vs $3.28+0.9% | $2.0Bvs $2.0B+3.0% |
Based on last 12 quarters of dataView full earnings history →
ICLR Peer Comparison
ICON Public Limited Company (ICLR) competitors in Contract Research and Preclinical Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CRL | 8.91B | 185.00 | -63.57 | -0.85% | -4.59% | -5.66% | 0.95 | |
 IQV | 28.47B | 167.77 | 21.40 | 5.87% | 8.33% | 22.11% | 2.44 | |
 MEDP | 13.14B | 460.20 | 30.12 | 19.97% | 17.19% | 120.89% | 0.55 | |
 PRA | 1.27B | 24.65 | 24.90 | -2.67% | 6.04% | 4.95% | 0.32 | |
 LH | 21.05B | 255.82 | 24.46 | 7.25% | 6.66% | 10.89% | 0.83 | |
 DGX | 21.58B | 195.00 | 22.29 | 11.78% | 9.08% | 13.8% | 0.95 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 |
Compare ICLR vs Peers
ICON Public Limited Company (ICLR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ICLR Income Statement
ICON Public Limited Company (ICLR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.76B | 2.6B | 2.81B | 2.8B | 5.48B | 7.74B | 8.12B | 8.28B | 8.25B |
Revenue Growth % | 5.52% | 47.62% | 8.09% | -0.3% | 95.93% | 41.24% | 4.89% | 1.99% | -0.37% |
Cost of Goods Sold | 1.03B | 1.83B | 1.97B | 1.99B | 3.97B | 5.53B | 5.72B | 5.85B | 6.08B |
COGS % of Revenue | 58.66% | 70.36% | 70.36% | 71.11% | 72.48% | 71.4% | 70.44% | 70.58% | 73.63% |
Gross Profit | 726.96M▲ 0% | 769.49M▲ 5.8% | 831.7M▲ 8.1% | 808.03M▼ 2.8% | 1.51B▲ 86.7% | 2.21B▲ 46.8% | 2.4B▲ 8.4% | 2.44B▲ 1.5% | 2.18B▼ 10.7% |
Gross Margin % | 41.34% | 29.64% | 29.64% | 28.89% | 27.52% | 28.6% | 29.56% | 29.42% | 26.37% |
Gross Profit Growth % | 3.09% | 5.85% | 8.09% | -2.85% | 86.65% | 46.82% | 8.39% | 1.51% | -10.7% |
Operating Expenses | 392.79M | 392.37M | 398.3M | 416.06M | 1.13B | 1.42B | 1.44B | 1.34B | 1.16B |
OpEx % of Revenue | 22.34% | 15.12% | 14.2% | 14.87% | 20.61% | 18.33% | 17.78% | 16.16% | 14.1% |
Selling, General & Admin | 323.74M | 325.79M | 336.75M | 341.69M | 585.33M | 778.75M | 776.36M | 728.35M | 780.14M |
SG&A % of Revenue | 18.41% | 12.55% | 12% | 12.21% | 10.68% | 10.06% | 9.56% | 8.79% | 9.45% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 69.05M | 66.58M | 61.55M | 74.38M | 544.36M | 640.35M | 667.72M | 610.2M | 383M |
Operating Income | 338.34M▲ 0% | 373.36M▲ 10.4% | 433.41M▲ 16.1% | 391.5M▼ 9.7% | 378.53M▼ 3.3% | 795.24M▲ 110.1% | 956.15M▲ 20.2% | 1.1B▲ 14.8% | 1.01B▼ 7.8% |
Operating Margin % | 19.24% | 14.38% | 15.45% | 14% | 6.91% | 10.27% | 11.77% | 13.26% | 12.27% |
Operating Income Growth % | 8.55% | 10.35% | 16.08% | -9.67% | -3.31% | 110.09% | 20.23% | 14.82% | -7.77% |
EBITDA | 399.59M | 439.27M | 525.33M | 486.11M | 738.86M | 1.41B | 1.54B | 1.59B | 1.4B |
EBITDA Margin % | 22.72% | 16.92% | 18.72% | 17.38% | 13.48% | 18.21% | 18.99% | 19.15% | 16.91% |
EBITDA Growth % | 7.63% | 9.93% | 19.59% | -7.47% | 51.99% | 90.83% | 9.37% | 2.87% | -12.03% |
D&A (Non-Cash Add-back) | 61.25M | 65.92M | 91.92M | 94.61M | 360.33M | 614.73M | 585.95M | 488.5M | 383M |
EBIT | 340.68M | 378.12M | 440.26M | 394.22M | 379.1M | 797.58M | 935.49M | 1.08B | 440.57M |
Net Interest Income | -10.28M | -8.74M | -6.42M | -10.29M | -181.85M | -227.39M | -331.69M | -228.63M | -181M |
Interest Income | 2.35M | 4.76M | 6.86M | 2.72M | 574K | 2.35M | 5.01M | 8.61M | 7.11M |
Interest Expense | 12.63M | 13.5M | 13.28M | 13.02M | 182.42M | 229.73M | 336.7M | 237.24M | 188.11M |
Other Income/Expense | -10.28M | -8.74M | -6.42M | -10.66M | -184.01M | -230.52M | -331.69M | -228.63M | -759.99M |
Pretax Income | 327.67M▲ 0% | 368.38M▲ 12.4% | 426.99M▲ 15.9% | 380.84M▼ 10.8% | 194.52M▼ 48.9% | 564.72M▲ 190.3% | 624.08M▲ 10.5% | 869.18M▲ 39.3% | 252.47M▼ 71.0% |
Pretax Margin % | 18.63% | 14.19% | 15.22% | 13.61% | 3.55% | 7.29% | 7.69% | 10.5% | 3.06% |
Income Tax | 46.57M | 45.56M | 51.13M | 47.88M | 41.33M | 59.41M | 11.75M | 77.71M | 23.13M |
Effective Tax Rate % | 14.21% | 12.37% | 11.98% | 12.57% | 21.25% | 10.52% | 1.88% | 8.94% | 9.16% |
Net Income | 281.49M▲ 0% | 322.82M▲ 14.7% | 373.99M▲ 15.9% | 327.81M▼ 12.3% | 153.19M▼ 53.3% | 505.3M▲ 229.9% | 612.34M▲ 21.2% | 791.47M▲ 29.3% | 229.34M▼ 71.0% |
Net Margin % | 16.01% | 12.44% | 13.33% | 11.72% | 2.79% | 6.53% | 7.54% | 9.56% | 2.78% |
Net Income Growth % | 7.36% | 14.68% | 15.85% | -12.35% | -53.27% | 229.87% | 21.18% | 29.26% | -71.02% |
Net Income (Continuing) | 281.49M | 322.66M | 375.86M | 332.96M | 153.19M | 505.3M | 612.34M | 791.47M | 229.34M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 5.13▲ 0% | 5.90▲ 15.0% | 6.79▲ 15.1% | 6.24▼ 8.1% | 2.25▼ 63.9% | 6.13▲ 172.4% | 7.40▲ 20.7% | 9.53▲ 28.8% | 2.90▼ 69.6% |
EPS Growth % | 10.32% | 15.01% | 15.08% | -8.1% | -63.94% | 172.44% | 20.72% | 28.78% | -69.57% |
EPS (Basic) | 5.20 | 5.96 | 6.85 | 6.29 | 2.28 | 6.20 | 7.46 | 9.60 | 2.92 |
Diluted Shares Outstanding | 54.87M | 54.74M | 54.33M | 53.28M | 68.07M | 82.47M | 82.72M | 83.03M | 78.97M |
Basic Shares Outstanding | 54.13M | 54.12M | 53.86M | 52.86M | 67.11M | 81.53M | 82.1M | 82.48M | 78.42M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ICLR Balance Sheet
ICON Public Limited Company (ICLR) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.1B | 1.33B | 1.62B | 2.1B | 2.94B | 3.23B | 3.41B | 3.53B | 3.5B |
Cash & Short-Term Investments | 360.45M | 455.76M | 569.94M | 842.03M | 753.92M | 290.48M | 380.06M | 538.78M | 647.29M |
Cash Only | 282.86M | 395.85M | 520.31M | 840.3M | 752.21M | 288.77M | 378.1M | 538.78M | 647.29M |
Short-Term Investments | 77.59M | 59.91M | 49.63M | 1.73M | 1.71M | 1.71M | 1.95M | 0 | 0 |
Accounts Receivable | 706.19M | 837.62M | 1.01B | 1.21B | 2.07B | 2.8B | 2.9B | 2.85B | 2.75B |
Days Sales Outstanding | 146.58 | 117.78 | 131.85 | 157.55 | 138.05 | 132.09 | 130.32 | 125.66 | 121.61 |
Inventory | 2.2M | 2.3M | 3.2M | 0 | 0 | 7.06M | 0 | 0 | 0 |
Days Inventory Outstanding | 0.78 | 0.46 | 0.59 | - | - | 0.47 | - | - | - |
Other Current Assets | 0 | 0 | -3.2M | 0 | 0 | 130.03M | 132.1M | 140.44M | 105.32M |
Total Non-Current Assets | 1.07B | 1.02B | 1.28B | 1.33B | 14.45B | 13.96B | 13.58B | 13.35B | 12.77B |
Property, Plant & Equipment | 105.1M | 103.71M | 270.06M | 258.9M | 534.57M | 504.15M | 501.52M | 530.48M | 524.67M |
Fixed Asset Turnover | 16.73x | 25.03x | 10.39x | 10.80x | 10.25x | 15.36x | 16.19x | 15.61x | 15.73x |
Goodwill | 783.07M | 770.27M | 883.17M | 936.26M | 9.04B | 8.97B | 9.02B | 9.05B | 8.73B |
Intangible Assets | 129.58M | 109.01M | 67.89M | 66.46M | 4.71B | 4.28B | 3.86B | 3.56B | 3.25B |
Long-Term Investments | 0 | 6.96M | 10.05M | 20.3M | 24.96M | 32.63M | 46.8M | 57.95M | 82.05M |
Other Non-Current Assets | 22.36M | 2.45M | 34.67M | 38M | 89.19M | 92.17M | 78.47M | 72.8M | 75.71M |
Total Assets | 2.19B▲ 0% | 2.35B▲ 7.7% | 2.91B▲ 23.5% | 3.44B▲ 18.2% | 17.39B▲ 406.1% | 17.19B▼ 1.2% | 16.99B▼ 1.1% | 16.88B▼ 0.7% | 16.27B▼ 3.6% |
Asset Turnover | 0.80x | 1.10x | 0.97x | 0.81x | 0.32x | 0.45x | 0.48x | 0.49x | 0.51x |
Asset Growth % | 19.72% | 7.7% | 23.5% | 18.16% | 406.09% | -1.16% | -1.14% | -0.66% | -3.6% |
Total Current Liabilities | 566.06M | 610.62M | 1.13B | 1.12B | 2.48B | 2.69B | 2.83B | 2.8B | 3.2B |
Accounts Payable | 18.59M | 13.29M | 24.05M | 51.11M | 226.98M | 611.4M | 595.47M | 704.59M | 780.85M |
Days Payables Outstanding | 6.58 | 2.66 | 4.45 | 9.38 | 20.85 | 40.38 | 38 | 44 | 46.91 |
Short-Term Debt | 0 | 0 | 349.64M | 0 | 55.15M | 55.15M | 110.15M | 29.76M | 529.76M |
Deferred Revenue (Current) | 299.03M | 274.51M | 367.03M | 660.93M | 1.32B | 1.51B | 1.65B | 1.61B | 1.55B |
Other Current Liabilities | 233.47M | 317.1M | 350.18M | 375.39M | 439.82M | 24.82M | 415.06M | 355.22M | 279.74M |
Current Ratio | 1.95x | 2.18x | 1.44x | 1.87x | 1.19x | 1.20x | 1.21x | 1.26x | 1.10x |
Quick Ratio | 1.94x | 2.17x | 1.43x | 1.87x | 1.19x | 1.20x | 1.21x | 1.26x | 1.10x |
Cash Conversion Cycle | 140.78 | 115.58 | 127.99 | - | - | 92.18 | - | - | - |
Total Non-Current Liabilities | 389.56M | 389.35M | 158.21M | 461.43M | 6.84B | 6B | 4.92B | 4.56B | 3.88B |
Long-Term Debt | 348.89M | 349.26M | 0 | 348.48M | 5.38B | 4.6B | 3.67B | 3.4B | 2.87B |
Capital Lease Obligations | 0 | 0 | 76.59M | 60.8M | 159.48M | 131.64M | 126.32M | 140.09M | 117.12M |
Deferred Tax Liabilities | 7.72M | 8.21M | 9.48M | 10.41M | 1.09B | 988.59M | 899.1M | 812.49M | 714.43M |
Other Non-Current Liabilities | 31.99M | 31M | 71.32M | 40.91M | 213.97M | 277.45M | 232.65M | 209.3M | 176.06M |
Total Liabilities | 955.62M | 999.97M | 1.29B | 1.59B | 9.32B | 8.69B | 7.75B | 7.35B | 7.08B |
Total Debt | 348.89M | 349.26M | 454.55M | 433.61M | 5.65B | 4.83B | 3.94B | 3.6B | 3.56B |
Net Debt | 66.03M | -46.59M | -65.76M | -406.69M | 4.89B | 4.54B | 3.56B | 3.06B | 2.91B |
Debt / Equity | 0.28x | 0.26x | 0.28x | 0.23x | 0.70x | 0.57x | 0.43x | 0.38x | 0.39x |
Debt / EBITDA | 0.87x | 0.80x | 0.87x | 0.89x | 7.64x | 3.43x | 2.55x | 2.27x | 2.55x |
Net Debt / EBITDA | 0.17x | -0.11x | -0.13x | -0.84x | 6.62x | 3.22x | 2.31x | 1.93x | 2.08x |
Interest Coverage | 26.98x | 28.00x | 33.16x | 30.28x | 2.08x | 3.47x | 2.78x | 4.53x | 2.34x |
Total Equity | 1.23B▲ 0% | 1.35B▲ 10.1% | 1.62B▲ 19.5% | 1.85B▲ 14.3% | 8.07B▲ 336.0% | 8.5B▲ 5.3% | 9.24B▲ 8.7% | 9.52B▲ 3.1% | 9.19B▼ 3.5% |
Equity Growth % | 30.16% | 10.08% | 19.48% | 14.35% | 335.99% | 5.34% | 8.74% | 3.05% | -3.46% |
Book Value per Share | 22.42 | 24.74 | 29.78 | 34.72 | 118.51 | 103.05 | 111.71 | 114.69 | 116.42 |
Total Shareholders' Equity | 1.19B | 1.35B | 1.62B | 1.85B | 8.07B | 8.5B | 9.24B | 9.52B | 9.19B |
Common Stock | 4.66M | 4.66M | 4.63M | 4.58M | 6.64M | 6.65M | 6.7M | 6.59M | 6.3M |
Retained Earnings | 742.8M | 888.33M | 1.11B | 1.26B | 1.42B | 1.82B | 2.43B | 2.72B | 2.12B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -37.8M | -69.33M | -75.82M | -35.48M | -90.94M | -171.54M | -142.34M | -228.63M | -68.53M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ICLR Cash Flow Statement
ICON Public Limited Company (ICLR) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 383.08M | 264.01M | 412.54M | 594.72M | 829.14M | 563.32M | 1.16B | 1.29B | 1.04B |
Operating CF Margin % | 21.79% | 10.17% | 14.7% | 21.26% | 15.13% | 7.28% | 14.3% | 15.54% | 12.56% |
Operating CF Growth % | 47.79% | -31.08% | 56.26% | 44.16% | 39.42% | -32.06% | 106.11% | 10.82% | -19.46% |
Net Income | 24.23M | 322.82M | 375.86M | 331.43M | 153.19M | 505.3M | 612.34M | 791.47M | 229.34M |
Depreciation & Amortization | 191K | 65.92M | 61.55M | 95.07M | 314.99M | 569.51M | 585.95M | 528.29M | 383M |
Stock-Based Compensation | 21.63M | 28.06M | 26.82M | 26.27M | 133.84M | 70.52M | 55.67M | 45.87M | 102.04M |
Deferred Taxes | 10.73M | 45.56M | -1.54M | 50.75M | -60.62M | -124.98M | -85.4M | 0 | -128.92M |
Other Non-Cash Items | 323.61M | -20.68M | 32.6M | -23.51M | 152.75M | 93.18M | 107.3M | -22.47M | 548.85M |
Working Capital Changes | 2.69M | -177.65M | -82.74M | 114.71M | 135M | -550.22M | -114.82M | -56.51M | -98.1M |
Change in Receivables | 57.75M | -37.56M | -101.55M | -175.04M | 95.86M | -753.29M | -78.58M | 9.39M | -169.32M |
Change in Inventory | -45.19M | -38K | -69.7M | -1.63M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 2.53M | -5.07M | 3.44M | 26.49M | 0 | 0 | 0 | 0 | 0 |
Cash from Investing | -177.81M | -37.3M | -162.03M | -46.58M | -6.02B | -145.87M | -226.65M | -266.79M | -187.53M |
Capital Expenditures | -28K | -48.4M | -50.65M | -51.05M | -93.75M | -142.16M | -140.69M | -168.06M | -174.21M |
CapEx % of Revenue | 0% | 1.86% | 1.8% | 1.83% | 1.71% | 1.84% | 1.73% | 2.03% | 2.11% |
Acquisitions | 89.8M | -1.65M | -119.58M | -40.21M | -5.92B | -1.91M | -71.77M | -84.16M | -2.54M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -258.97M | 0 | 0 | 0 | -10M | 1.91M | 0 | 0 | 0 |
Cash from Financing | -119.28M | -108.4M | -125.41M | -235.02M | 5.11B | -864.17M | -844.04M | -837.18M | -771.26M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 5.03B | -800M | -895M | -360.28M | -29.76M |
Equity Issued (Net) | -133.11M | -128.96M | -146.93M | -175M | 117.74M | -64.14M | 50.97M | -463.81M | -740.28M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -133.11M | -128.96M | -146.93M | -175M | 0 | -99.98M | 0 | -500M | -750M |
Other Financing | 13.83M | 20.56M | 21.52M | -60.02M | -30.33M | -34K | -16K | -13.09M | -1.22M |
Net Change in Cash | 90.32M▲ 0% | 112.99M▲ 25.1% | 124.46M▲ 10.1% | 320M▲ 157.1% | -88.09M▼ 127.5% | -463.44M▼ 426.1% | 89.33M▲ 119.3% | 160.68M▲ 79.9% | 108.51M▼ 32.5% |
Free Cash Flow | 48.71M▲ 0% | 215.62M▲ 342.6% | 361.9M▲ 67.8% | 543.67M▲ 50.2% | 735.39M▲ 35.3% | 421.15M▼ 42.7% | 1.02B▲ 142.3% | 1.12B▲ 9.6% | 861.99M▼ 22.9% |
FCF Margin % | 2.77% | 8.31% | 12.9% | 19.44% | 13.42% | 5.44% | 12.57% | 13.51% | 10.45% |
FCF Growth % | -77.51% | 342.63% | 67.84% | 50.23% | 35.26% | -42.73% | 142.27% | 9.63% | -22.94% |
FCF per Share | 0.89 | 3.94 | 6.66 | 10.20 | 10.80 | 5.11 | 12.34 | 13.47 | 10.92 |
FCF Conversion (FCF/Net Income) | 1.36x | 0.82x | 1.10x | 1.81x | 5.41x | 1.11x | 1.90x | 1.63x | 4.52x |
Interest Paid | 13.09M | 13.06M | 13.06M | 13.06M | 106.2M | 210.92M | 317.98M | 0 | 0 |
Taxes Paid | 12.3M | 18.56M | 29.84M | 27.6M | 55.1M | 116.32M | 163.78M | 0 | 0 |
ICLR Key Ratios
ICON Public Limited Company (ICLR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 30.68% | 25.88% | 24.98% | 25.16% | 18.9% | 3.09% | 6.1% | 6.9% | 8.44% | 2.45% |
Return on Invested Capital (ROIC) | 22.14% | 21.17% | 21.51% | 22.73% | 19.6% | 3.94% | 4.59% | 5.55% | 6.49% | 6.15% |
Gross Margin | 42.31% | 41.34% | 29.64% | 29.64% | 28.89% | 27.52% | 28.6% | 29.56% | 29.42% | 26.37% |
Net Margin | 15.73% | 16.01% | 12.44% | 13.33% | 11.72% | 2.79% | 6.53% | 7.54% | 9.56% | 2.78% |
Debt / Equity | 0.37x | 0.28x | 0.26x | 0.28x | 0.23x | 0.70x | 0.57x | 0.43x | 0.38x | 0.39x |
Interest Coverage | 24.59x | 26.98x | 28.00x | 33.16x | 30.28x | 2.08x | 3.47x | 2.78x | 4.53x | 2.34x |
FCF Conversion | 0.99x | 1.36x | 0.82x | 1.10x | 1.81x | 5.41x | 1.11x | 1.90x | 1.63x | 4.52x |
Revenue Growth | 5.81% | 5.52% | 47.62% | 8.09% | -0.3% | 95.93% | 41.24% | 4.89% | 1.99% | -0.37% |
Related:ICLR Dividend History·ICLR Revenue History·ICLR Price History·ICLR P/E History·ICLR Financial Ratios·ICLR Institutional Holders
ICLR Frequently Asked Questions
ICON Public Limited Company (ICLR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
ICON Public Limited Company (ICLR) reported $8.17B in revenue for fiscal year 2025. This represents a 14549% increase from $55.8M in 1998.
ICON Public Limited Company (ICLR) saw revenue decline by 0.4% over the past year.
Yes, ICON Public Limited Company (ICLR) is profitable, generating $488.7M in net income for fiscal year 2025 (2.8% net margin).
Dividend & Returns
ICON Public Limited Company (ICLR) has a return on equity (ROE) of 2.5%. This is below average, suggesting room for improvement.
ICON Public Limited Company (ICLR) generated $1.34B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.